Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Jimenez-Alesanco

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
ACS Applied Materials & Interfaces|January 21, 2021
Enzyme/Nanocopper Hybrid Nanozymes: Modulating Enzyme-like Activity by the Protein Structure for Biosensing and Tumor Catalytic TherapyNoelia Losada-Garcia, Ana Jimenez-Alesanco, Adrian Velazquez-Campoy, et al.
International Journal of Biological Macromolecules|August 4, 2020
Structural stability of SARS-CoV-2 3CLpro and identification of quercetin as an inhibitor by experimental screeningOlga Abian, David Ortega-Alarcon, Ana Jimenez-Alesanco, et al.
Protein Science : a Publication of the Protein Society|September 29, 2022
Repositioning small molecule drugs as allosteric inhibitors of the BFT-3 toxin from enterotoxigenic Bacteroides fragilisAna Jimenez-Alesanco, Ulrich Eckhard, Marta Asencio Del Rio, et al.
Pharmaceuticals (Basel, Switzerland)|September 28, 2021
Sub-Micromolar Inhibition of SARS-CoV-2 3CLpro by Natural CompoundsBruno Rizzuti, Laura Ceballos-Laita, David Ortega-Alarcon, et al.
Biomedicines|April 30, 2021
Rutin Is a Low Micromolar Inhibitor of SARS-CoV-2 Main Protease 3CLpro: Implications for Drug Design of Quercetin AnalogsBruno Rizzuti, Fedora Grande, Filomena Conforti, et al.
Pharmaceuticals (Basel, Switzerland)|April 28, 2023
Autochthonous Peruvian Natural Plants as Potential SARS-CoV-2 M<sup>pro</sup> Main Protease InhibitorsMaria Nuria Peralta-Moreno, Vanessa Anton-Muñoz, David Ortega-Alarcon, et al.
Scientific Reports|November 28, 2024
Development of an efficient NUPR1 inhibitor with anticancer activityXi Liu, Ana Jimenez-Alesanco, Zexian Li, et al.
Molecules (Basel, Switzerland)|October 13, 2021
l-Arginine Improves Solubility and ANTI SARS-CoV-2 Mpro Activity of Rutin but Not the Antiviral Activity in CellsLuca Sancineto, Carmine Ostacolo, David Ortega-Alarcon, et al.
International Journal of Molecular Sciences|June 19, 2024
Shedding Light on Dark Chemical Matter: The Discovery of a SARS-CoV-2 M<sup>pro</sup> Main Protease Inhibitor through Intensive Virtual Screening and In Vitro EvaluationMaria Nuria Peralta-Moreno, Yago Mena, David Ortega-Alarcon, et al.
International Journal of Molecular Sciences|July 2, 2021
Seleno-Functionalization of Quercetin Improves the Non-Covalent Inhibition of M<sup>pro</sup> and Its Antiviral Activity in Cells against SARS-CoV-2Francesca Mangiavacchi, Pawel Botwina, Elena Menichetti, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
ACS Applied Materials & Interfaces|January 21, 2021
Enzyme/Nanocopper Hybrid Nanozymes: Modulating Enzyme-like Activity by the Protein Structure for Biosensing and Tumor Catalytic TherapyNoelia Losada-Garcia, Ana Jimenez-Alesanco, Adrian Velazquez-Campoy, et al.
International Journal of Biological Macromolecules|August 4, 2020
Structural stability of SARS-CoV-2 3CLpro and identification of quercetin as an inhibitor by experimental screeningOlga Abian, David Ortega-Alarcon, Ana Jimenez-Alesanco, et al.
Protein Science : a Publication of the Protein Society|September 29, 2022
Repositioning small molecule drugs as allosteric inhibitors of the BFT-3 toxin from enterotoxigenic Bacteroides fragilisAna Jimenez-Alesanco, Ulrich Eckhard, Marta Asencio Del Rio, et al.
Pharmaceuticals (Basel, Switzerland)|September 28, 2021
Sub-Micromolar Inhibition of SARS-CoV-2 3CLpro by Natural CompoundsBruno Rizzuti, Laura Ceballos-Laita, David Ortega-Alarcon, et al.
Biomedicines|April 30, 2021
Rutin Is a Low Micromolar Inhibitor of SARS-CoV-2 Main Protease 3CLpro: Implications for Drug Design of Quercetin AnalogsBruno Rizzuti, Fedora Grande, Filomena Conforti, et al.
Pharmaceuticals (Basel, Switzerland)|April 28, 2023
Autochthonous Peruvian Natural Plants as Potential SARS-CoV-2 M<sup>pro</sup> Main Protease InhibitorsMaria Nuria Peralta-Moreno, Vanessa Anton-Muñoz, David Ortega-Alarcon, et al.
Scientific Reports|November 28, 2024
Development of an efficient NUPR1 inhibitor with anticancer activityXi Liu, Ana Jimenez-Alesanco, Zexian Li, et al.
Molecules (Basel, Switzerland)|October 13, 2021
l-Arginine Improves Solubility and ANTI SARS-CoV-2 Mpro Activity of Rutin but Not the Antiviral Activity in CellsLuca Sancineto, Carmine Ostacolo, David Ortega-Alarcon, et al.
International Journal of Molecular Sciences|June 19, 2024
Shedding Light on Dark Chemical Matter: The Discovery of a SARS-CoV-2 M<sup>pro</sup> Main Protease Inhibitor through Intensive Virtual Screening and In Vitro EvaluationMaria Nuria Peralta-Moreno, Yago Mena, David Ortega-Alarcon, et al.
International Journal of Molecular Sciences|July 2, 2021
Seleno-Functionalization of Quercetin Improves the Non-Covalent Inhibition of M<sup>pro</sup> and Its Antiviral Activity in Cells against SARS-CoV-2Francesca Mangiavacchi, Pawel Botwina, Elena Menichetti, et al.
Pageof 1